Rockefeller Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Rockefeller Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.24K	Sell	62 -91	-59%	-$3.11K	﹤0.01%	4402
2026 Q1	$5.06K	Buy	153 +9	+6%	+$381	﹤0.01%	4239
2025 Q4	$6.67K	Sell	144 -160	-53%	-$6.69K	﹤0.01%	3970
2025 Q3	$10.6K	Buy	+304	New	+$10.6K	﹤0.01%	3621
2023 Q1	–	Sell	-64	Closed	-$1K	–	2342
2022 Q4	$1K	Sell	64 -50	-44%	-$1.01K	﹤0.01%	3658
2022 Q3	$1K	Buy	114 +9	+9%	+$159	﹤0.01%	3687
2022 Q2	$1K	Buy	105 +24	+30%	+$404	﹤0.01%	3923
2022 Q1	$1K	Buy	81 +50	+161%	+$945	﹤0.01%	3711
2021 Q4	$0	Buy	+31	New	+$604	﹤0.01%	3794
2020 Q4	–	Sell	-723	Closed	-$15K	–	2868
2020 Q3	$15K	Buy	723 +120	+20%	+$2.17K	﹤0.01%	1877
2020 Q2	$11K	Buy	603 +275	+84%	+$5.38K	﹤0.01%	1858
2020 Q1	$5K	Buy	+328	New	+$6.77K	﹤0.01%	1938

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Rockefeller Capital Management's COLL Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Collegium Pharmaceutical (COLL) stake by 59% in Q2 2026, selling an estimated $3.11K and leaving 62 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #4402.

Rockefeller Capital Management first reported a position in COLL in Q1 2020 and has held it in 12 quarters since. The position peaked at $15K in Q3 2020. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Rockefeller Capital Management held 62 shares of Collegium Pharmaceutical worth $2.24K as of Q2 2026.
Rockefeller Capital Management sold 91 Collegium Pharmaceutical shares in Q2 2026, an estimated $3.11K.
Collegium Pharmaceutical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4402 holding.
Rockefeller Capital Management first reported a position in Collegium Pharmaceutical in Q1 2020 and has held it in 12 quarters since.
Rockefeller Capital Management's Collegium Pharmaceutical position peaked at $15K in Q3 2020.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.